These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36174069)

  • 1. A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT).
    Tillmann HL; Suzuki A; Merz M; Hermann R; Rockey DC
    PLoS One; 2022; 17(9):e0271304. PubMed ID: 36174069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development.
    Hermann RP; Rockey DC; Suzuki A; Merz M; Tillmann HL
    Aliment Pharmacol Ther; 2022 Apr; 55(8):1028-1037. PubMed ID: 35266155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.
    Wang J; Ma Z; Niu M; Zhu Y; Liang Q; Zhao Y; Song J; Bai Z; Zhang Y; Zhang P; Li N; Meng Y; Li Q; Qin L; Teng G; Cao J; Li B; Chen S; Li Y; Zou Z; Zhou H; Xiao X
    Front Med; 2015 Dec; 9(4):457-67. PubMed ID: 26459430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Analysis of Drug-induced Liver Injury Caused by Polygonum multiflorum and its Preparations].
    Zhu Y; Liu SH; Wang JB; Song HB; Li YG; He TT; Ma X; Wang ZX; Wang-Li-ping ; Zhou K; Bai YF; Zou ZS; Xiao XH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Dec; 35(12):1442-7. PubMed ID: 26882605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of intrinsic hepatotoxic compounds in Polygonum multiflorum Thunb. using machine-learning methods.
    Hu X; Du T; Dai S; Wei F; Chen X; Ma S
    J Ethnopharmacol; 2022 Nov; 298():115620. PubMed ID: 35963419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signatures in drug-induced liver injury.
    Tillmann HL; Rockey DC
    Curr Opin Gastroenterol; 2020 May; 36(3):199-205. PubMed ID: 32205565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tools for causality assessment in drug-induced liver disease.
    Tillmann HL; Suzuki A; Barnhart HX; Serrano J; Rockey DC
    Curr Opin Gastroenterol; 2019 May; 35(3):183-190. PubMed ID: 30865042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of liver biopsy in the diagnosis of drug-induced liver injury.
    Ahmad J; Barnhart HX; Bonacini M; Ghabril M; Hayashi PH; Odin JA; Rockey DC; Rossi S; Serrano J; Tillmann HL; Kleiner DE;
    J Hepatol; 2022 May; 76(5):1070-1078. PubMed ID: 35074471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eighteen cases of liver injury following ingestion of Polygonum multiflorum.
    Dong H; Slain D; Cheng J; Ma W; Liang W
    Complement Ther Med; 2014 Feb; 22(1):70-4. PubMed ID: 24559819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Characterization of Cefazolin-Induced Liver Injury.
    Alqahtani SA; Kleiner DE; Ghabril M; Gu J; Hoofnagle JH; Rockey DC;
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1328-1336.e2. PubMed ID: 25528012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.
    Bessone F; Lucena MI; Roma MG; Stephens C; Medina-Cáliz I; Frider B; Tsariktsian G; Hernández N; Bruguera M; Gualano G; Fassio E; Montero J; Reggiardo MV; Ferretti S; Colombato L; Tanno F; Ferrer J; Zeno L; Tanno H; Andrade RJ
    Liver Int; 2016 Feb; 36(2):302-10. PubMed ID: 26104271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.
    Naseralallah LM; Aboujabal BA; Geryo NM; Al Boinin A; Al Hattab F; Akbar R; Umer W; Abdul Jabbar L; Danjuma MI
    PLoS One; 2022; 17(9):e0268705. PubMed ID: 36048762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
    Hey-Hadavi J; Seekins D; Palmer M; Coffey D; Caminis J; Abdullaev S; Patwardhan M; Tyler H; Raheja R; Stanley AM; Pineda-Salgado L; Bourdet DL; Andrade RJ; Hayashi PH; Dimick-Santos L; Rockey DC; Estilo A
    Drug Saf; 2021 Jun; 44(6):619-634. PubMed ID: 33725335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
    Andrade RJ; Lucena MI; Fernández MC; Pelaez G; Pachkoria K; García-Ruiz E; García-Muñoz B; González-Grande R; Pizarro A; Durán JA; Jiménez M; Rodrigo L; Romero-Gomez M; Navarro JM; Planas R; Costa J; Borras A; Soler A; Salmerón J; Martin-Vivaldi R;
    Gastroenterology; 2005 Aug; 129(2):512-21. PubMed ID: 16083708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Diagnose and Exclude Drug-Induced Liver Injury.
    Watkins PB
    Dig Dis; 2015; 33(4):472-6. PubMed ID: 26159261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.
    Palmer M; Kleiner DE; Goodman Z; Brunt E; Avigan MI; Regev A; Hayashi PH; Lewis JH; Mehta R; Harrison SA; Siciliano M; McWherter CA; Vuppalanchi R; Behling C; Miller V; Chalasani N; Sanyal AJ
    Aliment Pharmacol Ther; 2024 Jan; 59(2):201-216. PubMed ID: 37877759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.